Results of world's first gene therapy trial for arthritis show approach safe, feasible ( apable of replication in their patients...)

Results of world's first gene therapy trial for arthritis show approach safe, feasible

apable of replication in their patients.

"At the outset, our primary objective was proving the safety of gene therapy, especially for a clinical application to a nonlethal disease, such as arthritis. Once we learned of the adverse events in the X-SCID trial, we decided it was best to extend follow-up of our patients to five years so that there'd be little question about long-term safety," explained Christopher H. Evans, Ph.D., D.Sc., the study's lead author, now director of the Center for Molecular Orthopaedics at Brigham and Women's Hospital and Robert Lovett Professor of Orthopaedic Surgery at Harvard Medical School.

In rheumatoid arthritis, immune system cells called macrophages and lymphocytes colonize the lining of joints where they release proteins called cytokines that modulate communication between the immune cells and synovial cells, the cells that line the joint. As the researchers discovered in earlier animal studies, synovial cells have a receptor on their surface that's a perfect fit for a particular cytokine, interleukin-1, or IL-1. Like a switch, when IL-1 binds to this receptor, the cell unleashes additional biochemical agents, which in turn cause more local inflammation. As inflammation builds, patients experience progressively worse pain and stiffness in their affected joints.

To block this process, the team sought a way to prevent the main actor, IL-1, from binding to the synovial cells, and hence, setting off the destructive chain reaction that follows. In essence, they needed a way to plug up the receptor and found such a device in a gene encoding the IL-1 receptor antagonist, or IL-1 Ra.

Because it was the first trial of its kind and safety was a key concern, the protocol was designed so that the gene would be delivered to cells that had previously been removed from patients and then, after gene transfer, reintroduced several weeks later after intensive screening and determination of gene expression.

"Giv
'"/>

Source:Brigham and Women's Hospital

Page: 1 2 3 4
Related biology news :

1. Combating anthrax: Results of study published this month as researchers look for a better vaccine
2. Results with newer bladeless LASIK equivalent to standard microkeratome LASIK
3. PCRM develops worlds first cruelty-free insulin assay
4. Breakthrough: Scientists create worlds tiniest organic particles
5. Environmental lessons from tsunami as worlds coastal population doubles
6. New plant DNA libraries provides massive boost to worlds plant researchers
7. New book highlights worlds borderless conservation areas
8. Some good news for the worlds poor
9. New study of the worlds smallest elephant
10. The worlds deepest dinosaur finding - 2256 metres below the seabed
11. Scientists a step closer to protecting worlds most important crop

Post Your Comments:

(Date:12/16/2009)... -- BIO-key International, Inc. (OTC Bulletin Board: ... and finger-based biometric identification solutions, announced that ... Special Shareholder Meeting held today approved the ... to Interact911 Mobile Systems Inc. Of the ... and 1.2% were opposed. ,, (Logo: ...

(Date:12/16/2009)... -- CSC (NYSE: CSC ) ... Laboratory Accreditation awarded the International Organization for ... the company,s Test Lab, which is part ... Fairmont, W.Va. The Test Lab is the ... to achieve this accomplishment. ,, (Logo: ...

(Date:12/15/2009)... diseases such as Alzheimer,s and Parkinson,s, doctors can reach ... a patient. , But they come up empty-handed when ... with ataxia disabling disorders that rob people of ... are trying to change that with the help of ... of Neurological Disorders and Stroke to establish a nationwide ...

Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2 BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3 CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2 UF to lead national effort to help patients with rare brain disease 2 UF to lead national effort to help patients with rare brain disease 3 New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 1 New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 2 New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 3 New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 4 New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 5 Sirion Therapeutics Announces FDA Approval of Zirgan 28TM 29 28Ganciclovir Ophthalmic Gel 29 0 15 25 for Herpetic Keratitis 57895 1 Sirion Therapeutics Announces FDA Approval of Zirgan 28TM 29 28Ganciclovir Ophthalmic Gel 29 0 15 25 for Herpetic Keratitis 57895 2 Sirion Therapeutics Announces FDA Approval of Zirgan 28TM 29 28Ganciclovir Ophthalmic Gel 29 0 15 25 for Herpetic Keratitis 57895 3 Sirion Therapeutics Announces FDA Approval of Zirgan 28TM 29 28Ganciclovir Ophthalmic Gel 29 0 15 25 for Herpetic Keratitis 57895 4 Advanced Analogic Technologies Introduces Lowest Power Load Switch Available for Biometric Security Devices 10022 1 Advanced Analogic Technologies Introduces Lowest Power Load Switch Available for Biometric Security Devices 10022 2 Advanced Analogic Technologies Introduces Lowest Power Load Switch Available for Biometric Security Devices 10022 3

[0] BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division [0] CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation [0] UF to lead national effort to help patients with rare brain disease

... as key to Komodo Dragon,s hunting strategy. , A ... Komodo Dragon bite is a combination of highly specialized ... widely accepted theory that prey die from septicemia caused ... Using sophisticated medical imaging techniques, an international team led ...

... the palm of your hand can never give accurate results. Whether ... job interview, you,re better off asking a trusted friend if your ... you need one? , Tel Aviv University researchers have come ... lets you know if malodorous bacteria are brewing in your mouth. ...

... By creating a model of the active site found ... Illinois have described a catalyst that acts like nature,s most ... a paper accepted for publication in the Journal of ... Web site. , Scientists have long been puzzled by nature,s ...

Other Biology News:A combined tooth-venom arsenal revealed as key to Komodo dragon's hunting strategy 2 Are you okay to kiss? 2 Are you okay to kiss? 3

A combined tooth-venom arsenal revealed as key to Komodo dragon's hunting strategy Are you okay to kiss?Synthetic catalyst mimics nature's 'hydrogen economy'

(Date:12/16/2009)... Trial conducted pursuant to Special Protocol Assessment ... QUEBEC CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna ... AEZ) (the "Company"), a global biopharmaceutical company ... announced the initiation, by its partner Keryx ... Phase 3 registration clinical trial for perifosine ...

(Date:12/16/2009)... has been found to be effectinve in improving yelds of probiotic ... ... BioSciences, LLC. ( www.nu-tekproducts.com ) is meeting the demand for Non-Animal ... Nutricepts, Inc. (Burnsville, Mn), is a high quality Soy Peptone. ... has been found to be especially effective in improving yields of ...

(Date:12/15/2009)... Joint BioEnergy Institute (JBEI), one of three Department of ... trusted time-stamping service to protect its valuable intellectual property. ... ... VA (PRWEB) December 15, 2009 -- Surety, LLC ... solutions , today announced that the Joint BioEnergy Institute ...

(Date:12/15/2009)... -- Reportlinker.com announces that a new market ... ,, The Future of Orphan ... Pipeline Analysis and Reimbursement ,, ... Summary ,, The author has ... Orphan Diseases Therapeutics - Market Forecasts to ...

[0] AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma [0] Nu-Tek BioSciences, LLC. Launches Animal-Free, Non-GM Soy Peptone [0] Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property [0] Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement

... WALL, N.J., Oct. 24 BIO-key International,Inc. ... public safety,solutions and finger based biometric identification, today ... Colorado Police Department,to implement the final phase of ... of BIO-key,s Mobile Office(TM) solution. The new system,will ...

... First Nine Months of 2007 - Continued Strong Organic Growth, With Revenue Up 8.5% Like-for-Like ... months ended September 30,2007. Consolidated revenue for the first nine months, EUR millions ... 2006 (9 % change Like-for-like ... months) months) ...

... Universitys Center for Applied Nanoionics (CANi) has a new take ... capacity and battery life of consumer electronics from digital cameras ... common materials and compatible with just about anything currently on ... provided a way for this memory to be made at ...

Other Biology Technology:BIO-key(R) Awarded Contract to Deploy Incident Reporting System for Littleton, CO Police Department 2 Essilor's 2007 Third-Quarter Report 2 Essilor's 2007 Third-Quarter Report 3 Essilor's 2007 Third-Quarter Report 4 ASU researchers improve memory devices using nanotech 2 ASU researchers improve memory devices using nanotech 3

BIO-key(R) Awarded Contract to Deploy Incident Reporting System for Littleton, CO Police Department Essilor's 2007 Third-Quarter Report ASU researchers improve memory devices using nanotech

Caspr2 Antigen: Fusion protein amino acids 96-1265 (extracellular domain) of human Caspr2 Accession Number: NP_054860...

... Sac-Cel (Second Antibody Coated CELlulose) was ... Diagnostics of Dartford, Kent, one of the ... world. IDS acquired the product range in ... and clinical biochemists developing their own "in ...

... standard is a new tuning and calibration ... mass spectrometry. Accumix is a lyophilized ... coverage for both tuning and calibration of ... and Fourier transform mass spectrometers. Direct ...

Determin interaction of your protein with Echelons lipids...

Biology Products:

Mouse Anti-Human Caspr2 Monoclonal Antibody, Unconjugated, Clone K67/25 from UC Davis/NINDS/NIMH NeuroMab Facility Anti-Sheep/Goat Sac-Cel - Solid-phase Separation System from IDS Ltd Accumix from Protea Biosciences, Inc.PIP Microstrips from Echelon Biosciences Inc.

( apable of replication in their patients...)Results of world's first gene therapy trial for arthritis show approach safe, feasible